Medical Care
Global Memantine Hydrochloride Extended-Release Capsule Market Research Report 2025
- Mar 11, 25
- ID: 14175
- Pages: 93
- Figures: 100
- Views: 1
The global market for Memantine Hydrochloride Extended-Release Capsule was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Memantine hydrochloride extended-release capsules are a medication used in the treatment of Alzheimer"s disease. The active ingredient in these capsules is memantine hydrochloride, which is a type of medication known as an N-methyl-D-aspartate (NMDA) receptor antagonist. Alzheimer"s disease is a progressive neurodegenerative disorder that affects memory, thinking, and behavior. It is characterized by the accumulation of a protein called beta-amyloid in the brain, leading to the death of nerve cells and the disruption of normal brain function.
North American market for Memantine Hydrochloride Extended-Release Capsule is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Memantine Hydrochloride Extended-Release Capsule is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Memantine Hydrochloride Extended-Release Capsule in Home is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Memantine Hydrochloride Extended-Release Capsule include Lundbeck, Allergan, Novartis, Lupin Ltd, Huahai Pharmaceutical, Daiichi Sankyo Company Limited, Rottendorf Pharma GmbH, Polygen Pharms, Macleods Pharms, Amneal Pharms, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Memantine Hydrochloride Extended-Release Capsule, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Memantine Hydrochloride Extended-Release Capsule.
The Memantine Hydrochloride Extended-Release Capsule market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Memantine Hydrochloride Extended-Release Capsule market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Memantine Hydrochloride Extended-Release Capsule companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lundbeck
Allergan
Novartis
Lupin Ltd
Huahai Pharmaceutical
Daiichi Sankyo Company Limited
Rottendorf Pharma GmbH
Polygen Pharms
Macleods Pharms
Amneal Pharms
Apeloa Pharmaceutical
HUMANWELL GROUP
Eisai Co
Ono Pharmaceutical
Slate Run
Easton Bio Pharmaceuticals
Segment by Type
7mg
14mg
21mg
28mg
Others
Segment by Application
Home
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Memantine Hydrochloride Extended-Release Capsule company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Memantine hydrochloride extended-release capsules are a medication used in the treatment of Alzheimer"s disease. The active ingredient in these capsules is memantine hydrochloride, which is a type of medication known as an N-methyl-D-aspartate (NMDA) receptor antagonist. Alzheimer"s disease is a progressive neurodegenerative disorder that affects memory, thinking, and behavior. It is characterized by the accumulation of a protein called beta-amyloid in the brain, leading to the death of nerve cells and the disruption of normal brain function.
North American market for Memantine Hydrochloride Extended-Release Capsule is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Memantine Hydrochloride Extended-Release Capsule is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Memantine Hydrochloride Extended-Release Capsule in Home is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Memantine Hydrochloride Extended-Release Capsule include Lundbeck, Allergan, Novartis, Lupin Ltd, Huahai Pharmaceutical, Daiichi Sankyo Company Limited, Rottendorf Pharma GmbH, Polygen Pharms, Macleods Pharms, Amneal Pharms, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Memantine Hydrochloride Extended-Release Capsule, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Memantine Hydrochloride Extended-Release Capsule.
The Memantine Hydrochloride Extended-Release Capsule market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Memantine Hydrochloride Extended-Release Capsule market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Memantine Hydrochloride Extended-Release Capsule companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lundbeck
Allergan
Novartis
Lupin Ltd
Huahai Pharmaceutical
Daiichi Sankyo Company Limited
Rottendorf Pharma GmbH
Polygen Pharms
Macleods Pharms
Amneal Pharms
Apeloa Pharmaceutical
HUMANWELL GROUP
Eisai Co
Ono Pharmaceutical
Slate Run
Easton Bio Pharmaceuticals
Segment by Type
7mg
14mg
21mg
28mg
Others
Segment by Application
Home
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Memantine Hydrochloride Extended-Release Capsule company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 7mg
1.2.3 14mg
1.2.4 21mg
1.2.5 28mg
1.2.6 Others
1.3 Market by Application
1.3.1 Global Memantine Hydrochloride Extended-Release Capsule Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Home
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Perspective (2020-2031)
2.2 Global Memantine Hydrochloride Extended-Release Capsule Growth Trends by Region
2.2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Region (2020-2025)
2.2.3 Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Region (2026-2031)
2.3 Memantine Hydrochloride Extended-Release Capsule Market Dynamics
2.3.1 Memantine Hydrochloride Extended-Release Capsule Industry Trends
2.3.2 Memantine Hydrochloride Extended-Release Capsule Market Drivers
2.3.3 Memantine Hydrochloride Extended-Release Capsule Market Challenges
2.3.4 Memantine Hydrochloride Extended-Release Capsule Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Memantine Hydrochloride Extended-Release Capsule Players by Revenue
3.1.1 Global Top Memantine Hydrochloride Extended-Release Capsule Players by Revenue (2020-2025)
3.1.2 Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Players (2020-2025)
3.2 Global Memantine Hydrochloride Extended-Release Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Memantine Hydrochloride Extended-Release Capsule Revenue
3.4 Global Memantine Hydrochloride Extended-Release Capsule Market Concentration Ratio
3.4.1 Global Memantine Hydrochloride Extended-Release Capsule Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Memantine Hydrochloride Extended-Release Capsule Revenue in 2024
3.5 Global Key Players of Memantine Hydrochloride Extended-Release Capsule Head office and Area Served
3.6 Global Key Players of Memantine Hydrochloride Extended-Release Capsule, Product and Application
3.7 Global Key Players of Memantine Hydrochloride Extended-Release Capsule, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Memantine Hydrochloride Extended-Release Capsule Breakdown Data by Type
4.1 Global Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Type (2020-2025)
4.2 Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Type (2026-2031)
5 Memantine Hydrochloride Extended-Release Capsule Breakdown Data by Application
5.1 Global Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Application (2020-2025)
5.2 Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Memantine Hydrochloride Extended-Release Capsule Market Size (2020-2031)
6.2 North America Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025)
6.4 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Memantine Hydrochloride Extended-Release Capsule Market Size (2020-2031)
7.2 Europe Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025)
7.4 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size (2020-2031)
8.2 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2020-2025)
8.4 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size (2020-2031)
9.2 Latin America Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025)
9.4 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size (2020-2031)
10.2 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025)
10.4 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lundbeck
11.1.1 Lundbeck Company Details
11.1.2 Lundbeck Business Overview
11.1.3 Lundbeck Memantine Hydrochloride Extended-Release Capsule Introduction
11.1.4 Lundbeck Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.1.5 Lundbeck Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Memantine Hydrochloride Extended-Release Capsule Introduction
11.2.4 Allergan Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Memantine Hydrochloride Extended-Release Capsule Introduction
11.3.4 Novartis Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Lupin Ltd
11.4.1 Lupin Ltd Company Details
11.4.2 Lupin Ltd Business Overview
11.4.3 Lupin Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.4.4 Lupin Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.4.5 Lupin Ltd Recent Development
11.5 Huahai Pharmaceutical
11.5.1 Huahai Pharmaceutical Company Details
11.5.2 Huahai Pharmaceutical Business Overview
11.5.3 Huahai Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.5.4 Huahai Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.5.5 Huahai Pharmaceutical Recent Development
11.6 Daiichi Sankyo Company Limited
11.6.1 Daiichi Sankyo Company Limited Company Details
11.6.2 Daiichi Sankyo Company Limited Business Overview
11.6.3 Daiichi Sankyo Company Limited Memantine Hydrochloride Extended-Release Capsule Introduction
11.6.4 Daiichi Sankyo Company Limited Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.6.5 Daiichi Sankyo Company Limited Recent Development
11.7 Rottendorf Pharma GmbH
11.7.1 Rottendorf Pharma GmbH Company Details
11.7.2 Rottendorf Pharma GmbH Business Overview
11.7.3 Rottendorf Pharma GmbH Memantine Hydrochloride Extended-Release Capsule Introduction
11.7.4 Rottendorf Pharma GmbH Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.7.5 Rottendorf Pharma GmbH Recent Development
11.8 Polygen Pharms
11.8.1 Polygen Pharms Company Details
11.8.2 Polygen Pharms Business Overview
11.8.3 Polygen Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.8.4 Polygen Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.8.5 Polygen Pharms Recent Development
11.9 Macleods Pharms
11.9.1 Macleods Pharms Company Details
11.9.2 Macleods Pharms Business Overview
11.9.3 Macleods Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.9.4 Macleods Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.9.5 Macleods Pharms Recent Development
11.10 Amneal Pharms
11.10.1 Amneal Pharms Company Details
11.10.2 Amneal Pharms Business Overview
11.10.3 Amneal Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.10.4 Amneal Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.10.5 Amneal Pharms Recent Development
11.11 Apeloa Pharmaceutical
11.11.1 Apeloa Pharmaceutical Company Details
11.11.2 Apeloa Pharmaceutical Business Overview
11.11.3 Apeloa Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.11.4 Apeloa Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.11.5 Apeloa Pharmaceutical Recent Development
11.12 HUMANWELL GROUP
11.12.1 HUMANWELL GROUP Company Details
11.12.2 HUMANWELL GROUP Business Overview
11.12.3 HUMANWELL GROUP Memantine Hydrochloride Extended-Release Capsule Introduction
11.12.4 HUMANWELL GROUP Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.12.5 HUMANWELL GROUP Recent Development
11.13 Eisai Co
11.13.1 Eisai Co Company Details
11.13.2 Eisai Co Business Overview
11.13.3 Eisai Co Memantine Hydrochloride Extended-Release Capsule Introduction
11.13.4 Eisai Co Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.13.5 Eisai Co Recent Development
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Details
11.14.2 Ono Pharmaceutical Business Overview
11.14.3 Ono Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.14.4 Ono Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.14.5 Ono Pharmaceutical Recent Development
11.15 Slate Run
11.15.1 Slate Run Company Details
11.15.2 Slate Run Business Overview
11.15.3 Slate Run Memantine Hydrochloride Extended-Release Capsule Introduction
11.15.4 Slate Run Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.15.5 Slate Run Recent Development
11.16 Easton Bio Pharmaceuticals
11.16.1 Easton Bio Pharmaceuticals Company Details
11.16.2 Easton Bio Pharmaceuticals Business Overview
11.16.3 Easton Bio Pharmaceuticals Memantine Hydrochloride Extended-Release Capsule Introduction
11.16.4 Easton Bio Pharmaceuticals Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.16.5 Easton Bio Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 7mg
1.2.3 14mg
1.2.4 21mg
1.2.5 28mg
1.2.6 Others
1.3 Market by Application
1.3.1 Global Memantine Hydrochloride Extended-Release Capsule Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Home
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Perspective (2020-2031)
2.2 Global Memantine Hydrochloride Extended-Release Capsule Growth Trends by Region
2.2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Region (2020-2025)
2.2.3 Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Region (2026-2031)
2.3 Memantine Hydrochloride Extended-Release Capsule Market Dynamics
2.3.1 Memantine Hydrochloride Extended-Release Capsule Industry Trends
2.3.2 Memantine Hydrochloride Extended-Release Capsule Market Drivers
2.3.3 Memantine Hydrochloride Extended-Release Capsule Market Challenges
2.3.4 Memantine Hydrochloride Extended-Release Capsule Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Memantine Hydrochloride Extended-Release Capsule Players by Revenue
3.1.1 Global Top Memantine Hydrochloride Extended-Release Capsule Players by Revenue (2020-2025)
3.1.2 Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Players (2020-2025)
3.2 Global Memantine Hydrochloride Extended-Release Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Memantine Hydrochloride Extended-Release Capsule Revenue
3.4 Global Memantine Hydrochloride Extended-Release Capsule Market Concentration Ratio
3.4.1 Global Memantine Hydrochloride Extended-Release Capsule Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Memantine Hydrochloride Extended-Release Capsule Revenue in 2024
3.5 Global Key Players of Memantine Hydrochloride Extended-Release Capsule Head office and Area Served
3.6 Global Key Players of Memantine Hydrochloride Extended-Release Capsule, Product and Application
3.7 Global Key Players of Memantine Hydrochloride Extended-Release Capsule, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Memantine Hydrochloride Extended-Release Capsule Breakdown Data by Type
4.1 Global Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Type (2020-2025)
4.2 Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Type (2026-2031)
5 Memantine Hydrochloride Extended-Release Capsule Breakdown Data by Application
5.1 Global Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Application (2020-2025)
5.2 Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Memantine Hydrochloride Extended-Release Capsule Market Size (2020-2031)
6.2 North America Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025)
6.4 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Memantine Hydrochloride Extended-Release Capsule Market Size (2020-2031)
7.2 Europe Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025)
7.4 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size (2020-2031)
8.2 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2020-2025)
8.4 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size (2020-2031)
9.2 Latin America Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025)
9.4 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size (2020-2031)
10.2 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025)
10.4 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lundbeck
11.1.1 Lundbeck Company Details
11.1.2 Lundbeck Business Overview
11.1.3 Lundbeck Memantine Hydrochloride Extended-Release Capsule Introduction
11.1.4 Lundbeck Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.1.5 Lundbeck Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Memantine Hydrochloride Extended-Release Capsule Introduction
11.2.4 Allergan Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Memantine Hydrochloride Extended-Release Capsule Introduction
11.3.4 Novartis Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Lupin Ltd
11.4.1 Lupin Ltd Company Details
11.4.2 Lupin Ltd Business Overview
11.4.3 Lupin Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.4.4 Lupin Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.4.5 Lupin Ltd Recent Development
11.5 Huahai Pharmaceutical
11.5.1 Huahai Pharmaceutical Company Details
11.5.2 Huahai Pharmaceutical Business Overview
11.5.3 Huahai Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.5.4 Huahai Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.5.5 Huahai Pharmaceutical Recent Development
11.6 Daiichi Sankyo Company Limited
11.6.1 Daiichi Sankyo Company Limited Company Details
11.6.2 Daiichi Sankyo Company Limited Business Overview
11.6.3 Daiichi Sankyo Company Limited Memantine Hydrochloride Extended-Release Capsule Introduction
11.6.4 Daiichi Sankyo Company Limited Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.6.5 Daiichi Sankyo Company Limited Recent Development
11.7 Rottendorf Pharma GmbH
11.7.1 Rottendorf Pharma GmbH Company Details
11.7.2 Rottendorf Pharma GmbH Business Overview
11.7.3 Rottendorf Pharma GmbH Memantine Hydrochloride Extended-Release Capsule Introduction
11.7.4 Rottendorf Pharma GmbH Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.7.5 Rottendorf Pharma GmbH Recent Development
11.8 Polygen Pharms
11.8.1 Polygen Pharms Company Details
11.8.2 Polygen Pharms Business Overview
11.8.3 Polygen Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.8.4 Polygen Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.8.5 Polygen Pharms Recent Development
11.9 Macleods Pharms
11.9.1 Macleods Pharms Company Details
11.9.2 Macleods Pharms Business Overview
11.9.3 Macleods Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.9.4 Macleods Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.9.5 Macleods Pharms Recent Development
11.10 Amneal Pharms
11.10.1 Amneal Pharms Company Details
11.10.2 Amneal Pharms Business Overview
11.10.3 Amneal Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.10.4 Amneal Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.10.5 Amneal Pharms Recent Development
11.11 Apeloa Pharmaceutical
11.11.1 Apeloa Pharmaceutical Company Details
11.11.2 Apeloa Pharmaceutical Business Overview
11.11.3 Apeloa Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.11.4 Apeloa Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.11.5 Apeloa Pharmaceutical Recent Development
11.12 HUMANWELL GROUP
11.12.1 HUMANWELL GROUP Company Details
11.12.2 HUMANWELL GROUP Business Overview
11.12.3 HUMANWELL GROUP Memantine Hydrochloride Extended-Release Capsule Introduction
11.12.4 HUMANWELL GROUP Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.12.5 HUMANWELL GROUP Recent Development
11.13 Eisai Co
11.13.1 Eisai Co Company Details
11.13.2 Eisai Co Business Overview
11.13.3 Eisai Co Memantine Hydrochloride Extended-Release Capsule Introduction
11.13.4 Eisai Co Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.13.5 Eisai Co Recent Development
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Details
11.14.2 Ono Pharmaceutical Business Overview
11.14.3 Ono Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.14.4 Ono Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.14.5 Ono Pharmaceutical Recent Development
11.15 Slate Run
11.15.1 Slate Run Company Details
11.15.2 Slate Run Business Overview
11.15.3 Slate Run Memantine Hydrochloride Extended-Release Capsule Introduction
11.15.4 Slate Run Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.15.5 Slate Run Recent Development
11.16 Easton Bio Pharmaceuticals
11.16.1 Easton Bio Pharmaceuticals Company Details
11.16.2 Easton Bio Pharmaceuticals Business Overview
11.16.3 Easton Bio Pharmaceuticals Memantine Hydrochloride Extended-Release Capsule Introduction
11.16.4 Easton Bio Pharmaceuticals Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
11.16.5 Easton Bio Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of 7mg
Table 3. Key Players of 14mg
Table 4. Key Players of 21mg
Table 5. Key Players of 28mg
Table 6. Key Players of Others
Table 7. Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2020-2025)
Table 11. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2026-2031)
Table 13. Memantine Hydrochloride Extended-Release Capsule Market Trends
Table 14. Memantine Hydrochloride Extended-Release Capsule Market Drivers
Table 15. Memantine Hydrochloride Extended-Release Capsule Market Challenges
Table 16. Memantine Hydrochloride Extended-Release Capsule Market Restraints
Table 17. Global Memantine Hydrochloride Extended-Release Capsule Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Players (2020-2025)
Table 19. Global Top Memantine Hydrochloride Extended-Release Capsule Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Memantine Hydrochloride Extended-Release Capsule as of 2024)
Table 20. Ranking of Global Top Memantine Hydrochloride Extended-Release Capsule Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Memantine Hydrochloride Extended-Release Capsule Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Memantine Hydrochloride Extended-Release Capsule, Headquarters and Area Served
Table 23. Global Key Players of Memantine Hydrochloride Extended-Release Capsule, Product and Application
Table 24. Global Key Players of Memantine Hydrochloride Extended-Release Capsule, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Type (2020-2025)
Table 28. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Type (2026-2031)
Table 30. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Application (2020-2025)
Table 32. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Application (2026-2031)
Table 34. North America Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031) & (US$ Million)
Table 49. Lundbeck Company Details
Table 50. Lundbeck Business Overview
Table 51. Lundbeck Memantine Hydrochloride Extended-Release Capsule Product
Table 52. Lundbeck Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 53. Lundbeck Recent Development
Table 54. Allergan Company Details
Table 55. Allergan Business Overview
Table 56. Allergan Memantine Hydrochloride Extended-Release Capsule Product
Table 57. Allergan Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 58. Allergan Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis Memantine Hydrochloride Extended-Release Capsule Product
Table 62. Novartis Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Lupin Ltd Company Details
Table 65. Lupin Ltd Business Overview
Table 66. Lupin Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 67. Lupin Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 68. Lupin Ltd Recent Development
Table 69. Huahai Pharmaceutical Company Details
Table 70. Huahai Pharmaceutical Business Overview
Table 71. Huahai Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 72. Huahai Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 73. Huahai Pharmaceutical Recent Development
Table 74. Daiichi Sankyo Company Limited Company Details
Table 75. Daiichi Sankyo Company Limited Business Overview
Table 76. Daiichi Sankyo Company Limited Memantine Hydrochloride Extended-Release Capsule Product
Table 77. Daiichi Sankyo Company Limited Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 78. Daiichi Sankyo Company Limited Recent Development
Table 79. Rottendorf Pharma GmbH Company Details
Table 80. Rottendorf Pharma GmbH Business Overview
Table 81. Rottendorf Pharma GmbH Memantine Hydrochloride Extended-Release Capsule Product
Table 82. Rottendorf Pharma GmbH Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 83. Rottendorf Pharma GmbH Recent Development
Table 84. Polygen Pharms Company Details
Table 85. Polygen Pharms Business Overview
Table 86. Polygen Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 87. Polygen Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 88. Polygen Pharms Recent Development
Table 89. Macleods Pharms Company Details
Table 90. Macleods Pharms Business Overview
Table 91. Macleods Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 92. Macleods Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 93. Macleods Pharms Recent Development
Table 94. Amneal Pharms Company Details
Table 95. Amneal Pharms Business Overview
Table 96. Amneal Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 97. Amneal Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 98. Amneal Pharms Recent Development
Table 99. Apeloa Pharmaceutical Company Details
Table 100. Apeloa Pharmaceutical Business Overview
Table 101. Apeloa Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 102. Apeloa Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 103. Apeloa Pharmaceutical Recent Development
Table 104. HUMANWELL GROUP Company Details
Table 105. HUMANWELL GROUP Business Overview
Table 106. HUMANWELL GROUP Memantine Hydrochloride Extended-Release Capsule Product
Table 107. HUMANWELL GROUP Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 108. HUMANWELL GROUP Recent Development
Table 109. Eisai Co Company Details
Table 110. Eisai Co Business Overview
Table 111. Eisai Co Memantine Hydrochloride Extended-Release Capsule Product
Table 112. Eisai Co Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 113. Eisai Co Recent Development
Table 114. Ono Pharmaceutical Company Details
Table 115. Ono Pharmaceutical Business Overview
Table 116. Ono Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 117. Ono Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 118. Ono Pharmaceutical Recent Development
Table 119. Slate Run Company Details
Table 120. Slate Run Business Overview
Table 121. Slate Run Memantine Hydrochloride Extended-Release Capsule Product
Table 122. Slate Run Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 123. Slate Run Recent Development
Table 124. Easton Bio Pharmaceuticals Company Details
Table 125. Easton Bio Pharmaceuticals Business Overview
Table 126. Easton Bio Pharmaceuticals Memantine Hydrochloride Extended-Release Capsule Product
Table 127. Easton Bio Pharmaceuticals Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 128. Easton Bio Pharmaceuticals Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 132. Authors List of This Report
List of Figures
Figure 1. Memantine Hydrochloride Extended-Release Capsule Picture
Figure 2. Global Memantine Hydrochloride Extended-Release Capsule Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Type: 2024 VS 2031
Figure 4. 7mg Features
Figure 5. 14mg Features
Figure 6. 21mg Features
Figure 7. 28mg Features
Figure 8. Others Features
Figure 9. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Application: 2024 VS 2031
Figure 11. Home Case Studies
Figure 12. Hospital Case Studies
Figure 13. Clinic Case Studies
Figure 14. Others Case Studies
Figure 15. Memantine Hydrochloride Extended-Release Capsule Report Years Considered
Figure 16. Global Memantine Hydrochloride Extended-Release Capsule Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Memantine Hydrochloride Extended-Release Capsule Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region: 2024 VS 2031
Figure 19. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Players in 2024
Figure 20. Global Top Memantine Hydrochloride Extended-Release Capsule Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Memantine Hydrochloride Extended-Release Capsule as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Memantine Hydrochloride Extended-Release Capsule Revenue in 2024
Figure 22. North America Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2020-2031)
Figure 24. United States Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2020-2031)
Figure 28. Germany Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2020-2031)
Figure 36. China Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2020-2031)
Figure 44. Mexico Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2020-2031)
Figure 48. Turkey Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Lundbeck Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 52. Allergan Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 54. Lupin Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 55. Huahai Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 56. Daiichi Sankyo Company Limited Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 57. Rottendorf Pharma GmbH Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 58. Polygen Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 59. Macleods Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 60. Amneal Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 61. Apeloa Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 62. HUMANWELL GROUP Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 63. Eisai Co Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 64. Ono Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 65. Slate Run Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 66. Easton Bio Pharmaceuticals Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of 7mg
Table 3. Key Players of 14mg
Table 4. Key Players of 21mg
Table 5. Key Players of 28mg
Table 6. Key Players of Others
Table 7. Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2020-2025)
Table 11. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2026-2031)
Table 13. Memantine Hydrochloride Extended-Release Capsule Market Trends
Table 14. Memantine Hydrochloride Extended-Release Capsule Market Drivers
Table 15. Memantine Hydrochloride Extended-Release Capsule Market Challenges
Table 16. Memantine Hydrochloride Extended-Release Capsule Market Restraints
Table 17. Global Memantine Hydrochloride Extended-Release Capsule Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Players (2020-2025)
Table 19. Global Top Memantine Hydrochloride Extended-Release Capsule Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Memantine Hydrochloride Extended-Release Capsule as of 2024)
Table 20. Ranking of Global Top Memantine Hydrochloride Extended-Release Capsule Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Memantine Hydrochloride Extended-Release Capsule Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Memantine Hydrochloride Extended-Release Capsule, Headquarters and Area Served
Table 23. Global Key Players of Memantine Hydrochloride Extended-Release Capsule, Product and Application
Table 24. Global Key Players of Memantine Hydrochloride Extended-Release Capsule, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Type (2020-2025)
Table 28. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Type (2026-2031)
Table 30. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Application (2020-2025)
Table 32. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Application (2026-2031)
Table 34. North America Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2026-2031) & (US$ Million)
Table 49. Lundbeck Company Details
Table 50. Lundbeck Business Overview
Table 51. Lundbeck Memantine Hydrochloride Extended-Release Capsule Product
Table 52. Lundbeck Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 53. Lundbeck Recent Development
Table 54. Allergan Company Details
Table 55. Allergan Business Overview
Table 56. Allergan Memantine Hydrochloride Extended-Release Capsule Product
Table 57. Allergan Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 58. Allergan Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis Memantine Hydrochloride Extended-Release Capsule Product
Table 62. Novartis Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Lupin Ltd Company Details
Table 65. Lupin Ltd Business Overview
Table 66. Lupin Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 67. Lupin Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 68. Lupin Ltd Recent Development
Table 69. Huahai Pharmaceutical Company Details
Table 70. Huahai Pharmaceutical Business Overview
Table 71. Huahai Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 72. Huahai Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 73. Huahai Pharmaceutical Recent Development
Table 74. Daiichi Sankyo Company Limited Company Details
Table 75. Daiichi Sankyo Company Limited Business Overview
Table 76. Daiichi Sankyo Company Limited Memantine Hydrochloride Extended-Release Capsule Product
Table 77. Daiichi Sankyo Company Limited Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 78. Daiichi Sankyo Company Limited Recent Development
Table 79. Rottendorf Pharma GmbH Company Details
Table 80. Rottendorf Pharma GmbH Business Overview
Table 81. Rottendorf Pharma GmbH Memantine Hydrochloride Extended-Release Capsule Product
Table 82. Rottendorf Pharma GmbH Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 83. Rottendorf Pharma GmbH Recent Development
Table 84. Polygen Pharms Company Details
Table 85. Polygen Pharms Business Overview
Table 86. Polygen Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 87. Polygen Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 88. Polygen Pharms Recent Development
Table 89. Macleods Pharms Company Details
Table 90. Macleods Pharms Business Overview
Table 91. Macleods Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 92. Macleods Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 93. Macleods Pharms Recent Development
Table 94. Amneal Pharms Company Details
Table 95. Amneal Pharms Business Overview
Table 96. Amneal Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 97. Amneal Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 98. Amneal Pharms Recent Development
Table 99. Apeloa Pharmaceutical Company Details
Table 100. Apeloa Pharmaceutical Business Overview
Table 101. Apeloa Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 102. Apeloa Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 103. Apeloa Pharmaceutical Recent Development
Table 104. HUMANWELL GROUP Company Details
Table 105. HUMANWELL GROUP Business Overview
Table 106. HUMANWELL GROUP Memantine Hydrochloride Extended-Release Capsule Product
Table 107. HUMANWELL GROUP Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 108. HUMANWELL GROUP Recent Development
Table 109. Eisai Co Company Details
Table 110. Eisai Co Business Overview
Table 111. Eisai Co Memantine Hydrochloride Extended-Release Capsule Product
Table 112. Eisai Co Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 113. Eisai Co Recent Development
Table 114. Ono Pharmaceutical Company Details
Table 115. Ono Pharmaceutical Business Overview
Table 116. Ono Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 117. Ono Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 118. Ono Pharmaceutical Recent Development
Table 119. Slate Run Company Details
Table 120. Slate Run Business Overview
Table 121. Slate Run Memantine Hydrochloride Extended-Release Capsule Product
Table 122. Slate Run Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 123. Slate Run Recent Development
Table 124. Easton Bio Pharmaceuticals Company Details
Table 125. Easton Bio Pharmaceuticals Business Overview
Table 126. Easton Bio Pharmaceuticals Memantine Hydrochloride Extended-Release Capsule Product
Table 127. Easton Bio Pharmaceuticals Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025) & (US$ Million)
Table 128. Easton Bio Pharmaceuticals Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 132. Authors List of This Report
List of Figures
Figure 1. Memantine Hydrochloride Extended-Release Capsule Picture
Figure 2. Global Memantine Hydrochloride Extended-Release Capsule Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Type: 2024 VS 2031
Figure 4. 7mg Features
Figure 5. 14mg Features
Figure 6. 21mg Features
Figure 7. 28mg Features
Figure 8. Others Features
Figure 9. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Application: 2024 VS 2031
Figure 11. Home Case Studies
Figure 12. Hospital Case Studies
Figure 13. Clinic Case Studies
Figure 14. Others Case Studies
Figure 15. Memantine Hydrochloride Extended-Release Capsule Report Years Considered
Figure 16. Global Memantine Hydrochloride Extended-Release Capsule Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Memantine Hydrochloride Extended-Release Capsule Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region: 2024 VS 2031
Figure 19. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Players in 2024
Figure 20. Global Top Memantine Hydrochloride Extended-Release Capsule Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Memantine Hydrochloride Extended-Release Capsule as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Memantine Hydrochloride Extended-Release Capsule Revenue in 2024
Figure 22. North America Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2020-2031)
Figure 24. United States Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2020-2031)
Figure 28. Germany Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2020-2031)
Figure 36. China Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2020-2031)
Figure 44. Mexico Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2020-2031)
Figure 48. Turkey Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Lundbeck Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 52. Allergan Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 54. Lupin Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 55. Huahai Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 56. Daiichi Sankyo Company Limited Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 57. Rottendorf Pharma GmbH Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 58. Polygen Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 59. Macleods Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 60. Amneal Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 61. Apeloa Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 62. HUMANWELL GROUP Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 63. Eisai Co Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 64. Ono Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 65. Slate Run Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 66. Easton Bio Pharmaceuticals Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Multi-Channel Temperature Controllers Market Research Report 2025
Mar 14, 25
Global Waterproof Action Cameras Market Research Report 2025
Mar 14, 25
Global Infrared IP Cameras Market Research Report 2025
Mar 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232